2009
DOI: 10.1016/j.chembiol.2009.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Design and Characterization of a Broad -Spectrum Bactericidal Acyl-lysyl Oligomer

Abstract: Previously characterized chemical mimics of host defense peptides belonging to the oligo-acyl-lysyl (OAK) family have so far failed to demonstrate broad-spectrum antibacterial potency combined with selectivity toward host cells. Here, we investigated OAK sequences and characterized a promising representative, designated C(12)K-3beta(10), with broad-spectrum activity (MIC(90) = 6.2 microM) and low hemotoxicity (LC(50) > 100 microM). Whereas C(12)K-3beta(10) exerted an essentially bactericidal effect, E. coli ba… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
35
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
6
2

Relationship

3
5

Authors

Journals

citations
Cited by 25 publications
(35 citation statements)
references
References 51 publications
0
35
0
Order By: Relevance
“…In addition, the OAK peptides are resistant to bacterial enzymatic degradation (13,67) and exhibit no or minimal cytotoxicity to mammalian cells (64,67). Furthermore, their structures can be fine tuned to optimize antibacterial activity (67), and they have been shown to possess significant in vivo efficacy against Escherichia coli (65,67) and Staphylococcus aureus (43,70) in mouse models of infection. Thus, OAKs display characteristic features that are attractive for the development of a potent new class of therapeutic drugs.…”
mentioning
confidence: 99%
“…In addition, the OAK peptides are resistant to bacterial enzymatic degradation (13,67) and exhibit no or minimal cytotoxicity to mammalian cells (64,67). Furthermore, their structures can be fine tuned to optimize antibacterial activity (67), and they have been shown to possess significant in vivo efficacy against Escherichia coli (65,67) and Staphylococcus aureus (43,70) in mouse models of infection. Thus, OAKs display characteristic features that are attractive for the development of a potent new class of therapeutic drugs.…”
mentioning
confidence: 99%
“…Recent designs have, moreover, shown potential for systemic efficacy (4,19,27), including upon coencapsulation with antibiotics in lipid vesicles (7,20). Among these, decanoyl-based OAKs were suggested to represent an efficient platform for the design of improved antibacterial compounds, as illustrated with the broadspectrum bactericidal sequence dodecanoyl-lysyl-[lysyl-aminodecanoyl-lysyl] 3 (C 12 K-3␤ 10 ), which demonstrated potential for systemic treatment of Staphylococcus aureus infection in mice (8). To follow up on these observations, we designed and tested a new series of decanoyl-based derivatives.…”
mentioning
confidence: 99%
“…In this respect, simple mimics of HDPs might be helpful in improving understanding of critical mechanistic steps. Among the classes of HDP mimics proposed, OAKs are quite interesting due to their remarkable simplicity.OAKs are composed of a small number of building blocks referred to as ␣ i (acyl-lysyl) or ␤ i (lysyl-acyl-lysyl) subunits (8,13,14), where i specifies the number of carbons in the acyl moiety (Fig. 1).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Various OAK sequences were shown to affect viability of a wide spectrum of bacterial species (30,38,44,49), while others displayed antiparasite (33, 37) or antitumor (26) activities. In each case, structure-activity relationship (SAR) studies have highlighted two major characteristics: selective cytotoxicity became apparent upon achievement of an optimal hydrophobicity and charge window (30,38,39), whereas poor performances of some of these lipopeptide-like compounds were often linked to the tendency of hydrophobic sequences to aggregate in solution (38,50).Some antibacterial aspects of the OAK sequence C 12 K-7␣ 8 (the molecular structure is shown in Fig. 1) were addressed in previous studies (15,31,39,44).…”
mentioning
confidence: 99%